Infectious Bovine Rhinotracheitis Resp

Infectious bovine rhinotracheitis is a highly contagious viral disease of cattle caused by bovine herpesvirus-1, representing one of the most significant respiratory pathogens affecting the global cattle industry. The disease is characterized by inflammation of the upper respiratory tract, including the nasal passages and trachea, often accompanied by fever, conjunctivitis, and in some cases reproductive complications including abortion. The colloquial name red nose refers to the characteristic inflammation and hyperemia of the nasal mucosa seen in affected animals. Understanding the biology of this herpesvirus infection, including its ability to establish lifelong latent infections, is essential for developing effective control strategies in cattle operations.

Infectious bovine rhinotracheitis affects cattle of all ages and breeds, with clinical disease most commonly observed in stressed animals such as those in feedlot situations, recently transported cattle, or animals experiencing other health challenges. The disease has a worldwide distribution, with serological surveys indicating that a large proportion of unvaccinated cattle populations have been exposed to the virus. Prevalence varies by region and management system, with intensive operations typically showing higher exposure rates than extensive grazing systems. The economic importance of IBR extends beyond direct mortality to include production losses, treatment costs, and trade restrictions, as some countries maintain IBR-free status and restrict cattle imports from endemic regions.

The economic and welfare impact of infectious bovine rhinotracheitis is substantial across both beef and dairy sectors. In feedlot cattle, IBR is a major component of the bovine respiratory disease complex that causes significant mortality and treatment costs. Dairy operations experience milk production losses during outbreak periods, along with reduced reproductive efficiency when the virus causes abortion or infertility. The cost of vaccination programs, while representing a valuable investment, adds to production expenses. Trade restrictions based on IBR status affect cattle movement between regions and countries, impacting marketing options and animal value. From a welfare perspective, affected cattle experience significant discomfort including painful breathing, eye irritation, and systemic illness that compromises their quality of life.

Infectious bovine rhinotracheitis cannot be cured once infection occurs, as no effective antiviral treatments are available for cattle, and the virus establishes lifelong latent infection in recovered animals. Management focuses on supportive care during acute illness and prevention through vaccination and biosecurity measures. Early recognition of clinical signs enables prompt supportive care and implementation of measures to limit spread within affected groups. Prevention through vaccination is highly effective and forms the cornerstone of IBR control in most cattle operations. Understanding that recovered animals remain latently infected and can reactivate and shed virus during stress is crucial for biosecurity and herd health management decisions.

The primary cause of infectious bovine rhinotracheitis is infection with bovine herpesvirus-1, an alphaherpesvirus that infects cattle and some other ruminant species. The virus is transmitted through direct contact with infected animals, through respiratory secretions containing virus particles, and potentially through fomites including contaminated equipment, clothing, and vehicles. Aerosol transmission can occur over short distances, particularly in confined housing where animals are in close proximity. The virus can also be transmitted venereally, causing genital infections, and can cross the placenta to infect fetuses, causing abortion. Following acute infection, the virus establishes latent infection in nerve ganglia, where it persists for the lifetime of the animal and can periodically reactivate to cause viral shedding without necessarily causing clinical signs.

Genetic susceptibility to infectious bovine rhinotracheitis does not follow clear breed patterns, as all cattle breeds appear susceptible to infection. However, individual variation in immune response and disease severity exists within populations. Animals with compromised immune function due to concurrent illness, malnutrition, or stress tend to experience more severe disease. Young calves with waning maternal antibody protection and naive adult cattle experiencing first exposure may show more severe clinical signs than animals with partial immunity from prior exposure or vaccination. There is no known genetic resistance to IBR infection that could be exploited in breeding programs.

Environmental and management factors strongly influence infectious bovine rhinotracheitis transmission and disease severity. Stress is a major factor affecting both susceptibility to clinical disease and reactivation of latent virus in carrier animals. Transportation, co-mingling of cattle from different sources, extreme weather conditions, and concurrent illness all create stress that promotes disease. Intensive housing with high stocking densities facilitates transmission through close contact and aerosol spread. Introduction of animals from unknown health status backgrounds brings potential for virus introduction. Inadequate vaccination protocols leave animals susceptible to infection when exposed.

Risk factors for infectious bovine rhinotracheitis outbreak include multiple management and operational variables. Feedlot entry, with the combination of transportation stress, co-mingling, and exposure to novel pathogens, represents a particularly high-risk period. Cattle markets and sales where animals from many sources mix create transmission opportunities. Breeding season and associated activities can spread the virus venereally and through close contact. Cold weather conditions that reduce ventilation in housed cattle and increase stress promote respiratory disease. Operations that do not maintain consistent vaccination programs have higher susceptibility to outbreaks. Purchase of cattle without testing or quarantine can introduce virus to naive herds.

The pathophysiology of infectious bovine rhinotracheitis involves viral invasion and destruction of respiratory epithelium. Following inhalation of virus-containing particles, initial replication occurs in the nasal mucosa and upper respiratory tract. The virus destroys epithelial cells, causing erosions, ulceration, and secondary bacterial invasion of damaged tissues. Inflammation causes the characteristic swelling, hyperemia, and discharge seen clinically. The virus spreads along nerve pathways to sensory ganglia, particularly the trigeminal ganglion, where latent infection is established. Systemic viremia can lead to infection of other tissues including the reproductive tract, causing abortion when virus infects the placenta and fetus. Immunosuppression during acute infection predisposes to secondary bacterial pneumonia, contributing to the bovine respiratory disease complex.

Early warning signs of infectious bovine rhinotracheitis often appear suddenly in affected individuals or groups. Fever is typically the first sign, with temperatures rising to 104-108 degrees Fahrenheit in the early stages of infection. Depression and reduced appetite accompany the fever, with affected cattle appearing dull and reluctant to eat or drink. Slight nasal discharge may be present early, progressing rapidly to more obvious signs. Increased respiratory rate and mild cough may be noted. Animals may separate from the group and show reduced interest in their surroundings. These early signs can be subtle in individual animals but become more apparent when multiple cattle are affected simultaneously.

Common symptoms of established infectious bovine rhinotracheitis create a distinctive clinical picture. The characteristic red nose appearance develops as nasal mucosa becomes intensely inflamed and hyperemic. Nasal discharge progresses from clear and watery to thick, mucopurulent material, often with blood streaking. Severe upper airway inflammation causes loud, labored breathing and increased respiratory effort. Conjunctivitis with ocular discharge affects many cases, with eyes appearing red and weepy. The muzzle may show erosions and crusting where discharge accumulates. Drooling and excessive salivation occur when mouth and throat are affected. Affected cattle show obvious illness including depression, complete anorexia, and reduced milk production in dairy animals.

Behavioral changes in cattle with infectious bovine rhinotracheitis reflect the systemic nature of the illness. Severely affected animals become markedly depressed and may stand with lowered heads, showing little response to their environment. Reluctance to move and preference for standing in sheltered areas are common. Affected cattle stop ruminating and show no interest in feed even when appetizing options are offered. Social behaviors are reduced, with sick animals separating from herd mates. In feedlot settings, affected cattle fall behind on feed consumption and may be found at the back of pens away from feeders and water. Pain from throat and airway inflammation may cause reluctance to vocalize.

Physical examination findings in infectious bovine rhinotracheitis cases are often dramatic. High fever, frequently exceeding 105 degrees Fahrenheit, is characteristic of acute infection. Examination of the nasal passages reveals intense inflammation, erosions, and mucopurulent discharge. The pharynx and larynx are swollen and inflamed, contributing to respiratory difficulty. Ocular examination shows conjunctival inflammation and discharge, sometimes with corneal opacity in severe cases. Auscultation of the chest may be normal if disease is limited to the upper respiratory tract, or may reveal signs of secondary bacterial pneumonia. Enlarged submandibular and pharyngeal lymph nodes are palpable in many cases. Dehydration from reduced water intake and fever-related fluid losses develops in affected animals.

Symptom progression in infectious bovine rhinotracheitis typically peaks within three to five days of initial signs. Fever may persist for several days before beginning to decline. Nasal discharge becomes increasingly purulent and may form crusts over the nostrils that impede breathing. Secondary bacterial infection of the damaged respiratory tract can lead to pneumonia, causing increased respiratory effort and potentially death. In pregnant cattle, abortion may occur days to weeks after acute infection, sometimes as the only sign of disease in animals that showed minimal respiratory signs. Eye involvement may progress to keratitis with corneal ulceration in some cases. Without complications, most animals begin to improve after approximately one week, though complete recovery takes longer.

Emergency symptoms requiring immediate veterinary intervention include severe respiratory distress with open-mouth breathing and cyanosis indicating inadequate oxygenation. High fever that fails to respond to supportive care or exceeds dangerous levels requires aggressive intervention. Secondary pneumonia with consolidated lung sounds and progressive deterioration demands prompt treatment. Abortion in valuable breeding animals necessitates investigation and preventive measures for other pregnant cattle. Rapid spread through a group with multiple severely affected animals requires immediate implementation of control measures. Any case showing neurological signs suggesting central nervous system involvement requires urgent evaluation.

Clinical examination provides the foundation for infectious bovine rhinotracheitis diagnosis, with the characteristic presentation often allowing presumptive diagnosis. The combination of acute high fever, nasal discharge, conjunctivitis, and the characteristic red nose appearance in cattle, particularly those recently stressed or co-mingled, strongly suggests IBR. Physical examination documents the extent of respiratory tract involvement and identifies secondary complications such as pneumonia. Assessment of multiple animals in affected groups reveals the typical pattern of rapid spread and similar clinical presentations. History of recent stress events, cattle movements, or known exposure provides supporting information.

Diagnostic testing confirms bovine herpesvirus-1 infection and distinguishes IBR from other respiratory pathogens. Virus isolation from nasal swabs collected during acute infection provides definitive diagnosis, though results are not immediately available. Polymerase chain reaction testing on nasal swabs or conjunctival swabs offers rapid and sensitive detection of viral DNA. Serology detects antibodies to the virus, with paired samples showing rising titers confirming recent infection. Single serology samples have limited value for acute diagnosis but help assess herd exposure status. In abortion cases, examination of fetal tissues and placenta with virus isolation or PCR confirms IBR as the cause. Fluorescent antibody testing on impression smears from affected tissues provides rapid diagnostic support.

Differential diagnosis for infectious bovine rhinotracheitis includes other causes of acute respiratory disease in cattle. Bovine respiratory syncytial virus causes respiratory disease with similar initial presentation but typically more lower respiratory involvement. Parainfluenza-3 virus causes milder respiratory signs. Bovine viral diarrhea virus can cause respiratory disease and immunosuppression predisposing to secondary infections. Bacterial pneumonia from various pathogens may follow or accompany viral infection. Malignant catarrhal fever causes severe disease with some similar features but typically more severe and often fatal course. Careful diagnostic workup distinguishes among these possibilities and identifies mixed infections common in bovine respiratory disease complex.

Herd-level diagnostics for infectious bovine rhinotracheitis inform control program development and monitor disease status. Bulk tank milk antibody testing in dairy herds provides efficient screening of herd exposure status. Individual serological testing identifies infected and carrier animals, though distinguishing vaccine antibodies from infection-induced antibodies requires specific testing approaches. Serological profiling across age groups reveals the pattern of infection in the herd. Abortion investigation protocols should include IBR testing when appropriate. Monitoring of respiratory disease incidence and response to vaccination programs helps evaluate control program effectiveness. Regular veterinary review of herd IBR status supports informed management decisions.

Emergency treatment for severe infectious bovine rhinotracheitis focuses on supportive care and prevention of complications, as no specific antiviral therapy is available. Anti-inflammatory medications including non-steroidal anti-inflammatory drugs help reduce fever and inflammation, improving comfort and appetite. Severely affected animals may benefit from systemic antibiotics to prevent or treat secondary bacterial infections of the damaged respiratory tract. Fluid therapy addresses dehydration from reduced intake and fever-related losses. Ensuring access to fresh water and palatable feed encourages intake during recovery. Severely compromised animals may require assisted feeding or tube administration of fluids. Isolation of affected animals from unexposed cattle limits disease spread.

Medical management of infectious bovine rhinotracheitis relies on supportive care and management of complications. Broad-spectrum antibiotics are commonly administered to prevent secondary bacterial pneumonia, a frequent and serious complication of IBR. Drug selection should consider common secondary pathogens including Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni. Treatment duration typically extends for three to five days or until clinical improvement is evident. Non-steroidal anti-inflammatory drugs provide fever control and reduce airway inflammation, making breathing easier. Appropriate withdrawal times must be observed for all medications administered to food-producing animals. Severely affected eyes with corneal involvement may benefit from topical antibiotic treatment to prevent secondary bacterial infection.

Surgical intervention plays no role in treating infectious bovine rhinotracheitis, as the condition is a systemic viral infection without focal lesions amenable to surgical correction. Tracheostomy might rarely be considered in cases of severe upper airway obstruction, but this represents an extreme and unusual situation. Management relies entirely on supportive care and antimicrobial treatment of secondary infections.

Supportive care is critical for successful management of infectious bovine rhinotracheitis cases. Providing clean, well-ventilated housing reduces respiratory stress and limits exposure to dust and irritants. Maintaining comfortable ambient temperatures reduces additional physiological stress on compromised animals. Soft, palatable feeds encourage intake in animals with sore throats and mouths. Clean, accessible water is essential for hydration and helps loosen respiratory secretions. Reducing handling stress allows animals to direct energy toward recovery. Separation of sick animals from healthy cattle limits transmission and provides a less competitive environment for recovery.

Herd treatment protocols during infectious bovine rhinotracheitis outbreaks combine individual animal care with population-level interventions. Mass medication of in-contact cattle with antibiotics may help prevent secondary bacterial complications in animals incubating the virus. Vaccination of unexposed animals in the face of an outbreak may provide some protection, though effectiveness varies based on the time course of exposure. Strict separation of affected and unaffected groups limits further spread. Environmental management including improved ventilation and reduced stocking density supports respiratory health. Stress reduction through minimizing handling, providing adequate feed and water, and maintaining comfortable conditions helps limit disease severity across the affected population.

Treatment decisions for infectious bovine rhinotracheitis must consider the self-limiting nature of uncomplicated infection while remaining vigilant for secondary complications. Mild cases may recover with minimal intervention, while severe cases or those developing pneumonia require aggressive treatment. The economic context of beef and dairy production influences treatment intensity decisions, balancing medication costs against animal value and production impacts. Animals that fail to respond to treatment or develop severe complications may warrant euthanasia on welfare and economic grounds. Veterinary involvement guides treatment decisions and helps develop herd-level response plans that address both immediate clinical needs and longer-term prevention.

Recovery timeline for infectious bovine rhinotracheitis varies based on disease severity and the development of complications. Uncomplicated cases typically show improvement in fever and appetite within five to seven days, with most clinical signs resolving over two weeks. Nasal discharge may persist for a week or more after fever resolves as damaged epithelium heals. Cases complicated by secondary bacterial pneumonia require longer recovery periods and may not fully resolve for three to four weeks or longer. Some animals develop chronic respiratory problems following severe infection. It is important to understand that recovered animals remain latently infected for life and can potentially reactivate and shed virus during future stress events.

Post-treatment care and monitoring during recovery from infectious bovine rhinotracheitis ensures continued progress and detects any complications. Temperature monitoring confirms fever resolution and helps detect secondary infections. Observation of respiratory rate and effort identifies animals developing pneumonia. Appetite and water intake monitoring ensures adequate nutrition and hydration for healing. Continued separation of recovered animals from naive cattle during the shedding period reduces transmission risk. Return to group housing and normal management should be gradual to minimize stress that could trigger viral reactivation. Follow-up veterinary examination of severely affected animals assesses recovery progress.

Prognosis factors for infectious bovine rhinotracheitis include disease severity at presentation, development of complications, and the animal's underlying health status. Uncomplicated upper respiratory infection carries a good prognosis with most animals making full clinical recovery. Secondary bacterial pneumonia significantly worsens the outlook, with some cases developing chronic respiratory problems or dying despite treatment. Eye involvement may result in permanent corneal scarring in some cases. Aborted pregnancies are obviously lost, though cows that abort typically recover normally otherwise. Animals that were stressed or debilitated prior to infection may experience more prolonged recovery.

Return to production considerations following infectious bovine rhinotracheitis must account for several factors. Milk production in dairy cattle typically returns to normal within days to weeks after clinical recovery. Growth rates in beef cattle may be reduced for a period following illness, potentially affecting time to market weight. Breeding decisions should consider the recent illness and ensure full recovery before breeding attempts. The permanent carrier status of recovered animals has implications for herd biosecurity, particularly when moving animals between operations or selling breeding stock. Documentation of infection history informs future health management decisions.

Vaccination protocols form the cornerstone of infectious bovine rhinotracheitis prevention in most cattle operations. Both modified live virus and killed virus vaccines are available, each with advantages and considerations. Modified live vaccines generally provide stronger, faster immunity and can be administered intranasally for rapid local protection. Killed vaccines are safer for pregnant animals and do not carry risk of vaccine-induced disease but may require multiple doses for full protection. Vaccination timing should ensure protection before high-risk periods such as feedlot entry or breeding season. Calf vaccination programs typically begin around three to four months of age when maternal antibody interference declines. Booster vaccinations maintain immunity throughout productive life. Vaccination does not eliminate infection but significantly reduces clinical disease severity and viral shedding.

Biosecurity measures can prevent infectious bovine rhinotracheitis introduction to naive herds or reduce transmission within infected populations. Closed herd policies that limit introduction of outside animals provide the strongest protection for negative herds. When purchases are necessary, sourcing from herds with known negative status or vaccination history reduces risk. Quarantine and testing of incoming animals before introduction to the main herd allows identification of infected individuals. Avoiding sharing of equipment, vehicles, and personnel between herds limits mechanical transmission. In countries with IBR eradication programs, strict movement controls and testing support progress toward elimination.

Nutritional prevention strategies support immune function and overall resilience to infectious challenge. Adequate protein and energy nutrition supports robust immune responses to both infection and vaccination. Trace mineral supplementation, particularly copper, zinc, and selenium, ensures immune system cofactors are available. Avoiding nutritional deficiencies that compromise immune function reduces disease susceptibility. Proper nutrition during stress periods such as weaning, transportation, and feedlot entry supports health during high-risk times. Good body condition entering high-risk periods provides reserves for fighting infection.

Management practices significantly influence infectious bovine rhinotracheitis risk and disease impact. Reducing stress through careful handling, gradual transitions, and maintaining consistent routines supports immune function. Avoiding co-mingling of cattle from multiple sources limits exposure to new virus strains. All-in-all-out management of feedlot pens reduces cycling of infection. Appropriate stocking densities allow adequate ventilation and reduce transmission. Isolation of sick animals limits spread during outbreaks. Ensuring newly arrived cattle are vaccinated and allowed to develop immunity before mixing with resident populations reduces introduction risk.

Quarantine and testing protocols support IBR control and eradication efforts. Incoming animals should be isolated and observed for respiratory disease signs before joining the main herd. Serological testing during quarantine identifies previously exposed animals. In herds attempting to achieve or maintain negative status, regular testing monitors success and identifies animals for removal. Testing paired with vaccination using marker vaccines allows differentiation of vaccinated from infected animals. Systematic testing and removal programs have achieved IBR eradication in several European countries and maintain negative status in valuable breeding populations.

Daily management and monitoring for infectious bovine rhinotracheitis prevention requires consistent attention to respiratory health and potential disease signs. Regular observation of cattle for nasal discharge, coughing, depression, or reduced appetite enables early disease detection. Temperature monitoring of animals showing early signs confirms fever and supports treatment decisions. Feed and water intake tracking reveals early impacts on consumption that may precede obvious clinical signs. Particular attention to recently arrived or stressed animals identifies high-risk individuals. Documentation of any respiratory disease cases supports trend analysis and veterinary consultation.

Housing and environmental management influences infectious bovine rhinotracheitis transmission and the ability of cattle to cope with infection. Adequate ventilation reduces airborne virus concentrations while maintaining comfortable temperatures. Appropriate stocking density provides sufficient space and reduces transmission through close contact. Isolation facilities enable separation of sick animals from healthy cattle. Clean, dry bedding supports overall health and immune function. Protection from extreme weather conditions reduces stress that can trigger viral reactivation in carrier animals. Facility design that minimizes stress during handling and movement supports respiratory health.

Herd health programs addressing infectious bovine rhinotracheitis integrate vaccination, biosecurity, and monitoring into comprehensive respiratory disease prevention. Vaccination schedules should be developed with veterinary input and maintained consistently. Biosecurity protocols address animal introductions, visitor access, and equipment sharing. Respiratory disease monitoring tracks incidence and allows early outbreak detection. Production records including growth rates, milk production, and reproductive efficiency reveal disease impacts. Regular veterinary review of IBR control program effectiveness guides adjustments. Coordination with other health programs creates comprehensive herd health support.

Record keeping and monitoring systems support effective infectious bovine rhinotracheitis management. Vaccination records document protection status and ensure timely boosters. Treatment records for respiratory disease cases enable tracking of incidence and treatment outcomes. Source and health history documentation for purchased animals supports biosecurity. Testing results for IBR status inform management decisions. Production data analysis reveals disease-related impacts on growth, milk production, and reproduction. Regular review of accumulated data identifies trends and guides program refinement.

Economic considerations for infectious bovine rhinotracheitis management include evaluation of prevention costs against potential disease impacts. Vaccination program costs represent a predictable, manageable expense that provides significant protection. The economic impact of IBR outbreaks includes treatment costs, mortality losses, reduced production, and abortions. Trade restrictions based on IBR status may affect marketing options and animal values. Cost-benefit analysis of different vaccination strategies helps optimize program design. Investment in biosecurity infrastructure and protocols pays dividends through reduced disease introduction risk. Regular economic review ensures resources are allocated effectively for respiratory disease prevention.

No specific cattle breeds demonstrate genetic immunity or particular susceptibility to infectious bovine rhinotracheitis, as bovine herpesvirus-1 can infect all cattle genetics. Beef and dairy breeds show similar susceptibility when management and exposure conditions are comparable. European cattle breeds, British breeds, and zebu-influenced breeds all experience IBR when exposed to the virus. Some breed associations maintain IBR-free status requirements for registered animals, reflecting herd health programs rather than genetic resistance. Individual variation in disease severity exists within populations, but clear breed-related patterns are not established.

Production type considerations influence infectious bovine rhinotracheitis exposure and disease patterns. Feedlot cattle experience high risk due to the combination of transportation stress, co-mingling, and exposure to animals from many sources. Dairy cattle in intensive operations face ongoing exposure risk and potential for transmission through shared facilities. Beef cattle on extensive rangelands may have lower exposure rates but remain susceptible when contact with infected animals occurs. Breeding herds maintaining closed status may remain negative, while those purchasing replacement animals face introduction risk. Show cattle with frequent transportation and contact with cattle from various sources represent high-risk populations.

Genetic selection and testing for infectious bovine rhinotracheitis addresses infection status rather than genetic resistance. Testing of breeding stock documents IBR status for health certification and sale purposes. Marker vaccine programs allow differentiation of vaccinated from infected animals through serological testing. Some breeding programs require negative IBR status for entry or sale, driving testing in seedstock populations. No genetic resistance to IBR has been identified that could be selected for in breeding programs. Future genomic research may identify genetic factors influencing disease severity or immune response, but current selection focuses on testing and management rather than genetic approaches.

Commonly co-occurring conditions with infectious bovine rhinotracheitis include other components of the bovine respiratory disease complex. Mannheimia haemolytica pneumonia frequently complicates IBR as secondary bacterial infection develops in virus-damaged respiratory tissue. Bovine respiratory syncytial virus may be present concurrently in respiratory disease outbreaks. Bovine viral diarrhea virus infection causes immunosuppression that worsens IBR and other respiratory diseases. Mycoplasma bovis contributes to respiratory disease in cattle and can accompany viral infections. Histophilus somni causes pneumonia and systemic disease that may occur alongside IBR. Concurrent parasitism or nutritional deficiencies compound immune challenge and worsen disease outcomes.

Conditions with similar symptoms that must be differentiated from infectious bovine rhinotracheitis include other causes of acute respiratory disease in cattle. Bovine respiratory syncytial virus causes respiratory disease but typically with more lower respiratory involvement. Malignant catarrhal fever causes severe disease with nasal and ocular signs but usually a more serious, often fatal course. Bovine viral diarrhea causes varied clinical presentations that may include respiratory signs. Upper respiratory bacterial infections may present similarly but typically without the characteristic viral syndrome. Foreign body obstruction can cause acute respiratory distress. Thorough diagnostic workup distinguishes among these possibilities and identifies mixed infections.

Complications and sequelae of infectious bovine rhinotracheitis extend beyond the acute respiratory disease. Secondary bacterial pneumonia is the most significant complication, adding morbidity and mortality to viral infection. Chronic respiratory disease may develop following severe pneumonia, with permanent lung damage affecting lifetime productivity. Corneal scarring from severe keratitis may cause permanent visual impairment. Abortion in pregnant cattle causes reproductive losses. Latent infection persists in all recovered animals, creating a reservoir for future outbreaks when stress triggers reactivation. Immunosuppression during acute infection increases susceptibility to other pathogens and disease complications.